Advisory Council

The Board of TOPRA is fortunate to be able to call on expert members of its Advisory Council for guidance. Appointed for terms of service of two years, the members of the Advisory Council cover many countries of the world and specialist areas.

All members of TOPRA can make recommendations to the Board, in confidence, for new Advisory Council members. The Council meets twice a year and provides a valuable external perspective on regulatory affairs and the needs of professionals in the discipline.

Council Members:

Dimitrios Athanasiou

European Medicines Agency

Peter Bachmann

Peter Bachmann

Federal Institute for Drugs and Medical Devices - BfArM (Germany)

Erik Briers

Erik Briers

Patient Expert Committee (Belgium)

Daniela Drago - GW University

Daniela Drago

Chief Regulatory Officer at Aurion Biotech

Jennifer Dudinak

Bristol-Myers Squibb (USA)

Sabine Haubenreisser

Sabine Haubenreisser

European Medicines Agency

Virginie Hivert

Virginie Hivert

EURORDIS

Lawrence Liberti - CIRS

Lawrence Liberti

Adjunct Assistant Professor at Temple University

Murray Lumpkin - Gates Foundation

Murray Lumpkin

Bill & Melinda Gates Foundation (USA)

Ian Hudson

Ian Hudson

Bill & Melinda Gates Foundation (USA)

Michael Kipping

Michael Kipping

Innovate UK

Mo Mansaray

Mo Mansaray

Senior Vice President at Organon & Co

Keith McDonald

Keith McDonald

IQVIA (UK)

Pat O'Mahony - MMI

Pat O'Mahony

Clinical Research Development Ireland (CRDI)

Karen Noonan

Karen Noonan

Association of Clinical Research Organizations (USA)

Roger Nosal

Pfizer Inc (USA)

Greg Perry - IFPMA

Greg Perry

International Federation of Pharmaceutical Manufacturers & Associations - IFPMA (Switzerland)

Tomas Salmonson - Swedish MPA

Tomas Salmonson

Consilium Salmonson & Hemmings
(Sweden)

Rui Santos Ivo - INFARMED IP

Rui Santos Ivo

Infarmed I.P. - National Authority for Medicines and Health Products (Portugal)

Mel Walker - Otsuka

Mel Walker

BioPharma Futures